Invesco Biotechnology & Genome ETF (PBE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Invesco Biotechnology & Genome ETF (PBE) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $247.8M, listed on AMEX, carrying a beta of 0.81 to the broader market. The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). public since 2005-06-23.
Snapshot as of May 15, 2026.
- Spot Price
- $81.02
- Total OI
- 19